Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
HIT HEADS: BCAA for Concussion
NCT01860404Phase 2Completed
- Sponsor
- Children's Hospital of Philadelphia
- Start
- Jan 2014
- Primary completion
- Jan 2023
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, randomised, double-blind trial of Branchamin in concussion (mTBI) (5 arms), sponsored by Children's Hospital of Philadelphia. Primary endpoint: Reaction Time Difference Between Drug and Placebo Groups at Day 21. Started Jan 2014; status: completed.
02
Drugs
Branchamin
03
Conditions
concussion (mTBI)
Beyond the preview
Go deeper on NCT01860404.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01860404.